Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant reported Q2 sales of $23.3 billion, up 27% year-over-year and higher than the Wall Street projection. Net income of $2.48 per share was also above the target that analysts had anticipated.
JNJ shares were trading flat immediately following the announcement. The stock has gained 7.6% since the beginning of this year.
The virus-driven shift in consumer behavior has made businesses revisit their strategies, and the alcohol industry is no exception. While the IPO frenzy continues unabated, led by the technology and
The food industry is witnessing a rebound as people revert to their earlier habits of eating out. Street food has always been popular among those who are looking for a
Financial services company The Charles Schwab Corporation (NYSE: SCHW) on Friday reported strong revenue and earnings growth for the third quarter. The numbers also beat Wall Street's forecast. Third-quarter revenues